Correlation Between Onconova Therapeutics and Ibio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Onconova Therapeutics and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onconova Therapeutics and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onconova Therapeutics and Ibio Inc, you can compare the effects of market volatilities on Onconova Therapeutics and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onconova Therapeutics with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onconova Therapeutics and Ibio.

Diversification Opportunities for Onconova Therapeutics and Ibio

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Onconova and Ibio is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Onconova Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onconova Therapeutics are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Onconova Therapeutics i.e., Onconova Therapeutics and Ibio go up and down completely randomly.

Pair Corralation between Onconova Therapeutics and Ibio

Given the investment horizon of 90 days Onconova Therapeutics is expected to generate 0.61 times more return on investment than Ibio. However, Onconova Therapeutics is 1.64 times less risky than Ibio. It trades about 0.06 of its potential returns per unit of risk. Ibio Inc is currently generating about 0.02 per unit of risk. If you would invest  76.00  in Onconova Therapeutics on August 29, 2024 and sell it today you would earn a total of  26.00  from holding Onconova Therapeutics or generate 34.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy31.45%
ValuesDaily Returns

Onconova Therapeutics  vs.  Ibio Inc

 Performance 
       Timeline  
Onconova Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconova Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Onconova Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Ibio Inc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.

Onconova Therapeutics and Ibio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Onconova Therapeutics and Ibio

The main advantage of trading using opposite Onconova Therapeutics and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onconova Therapeutics position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.
The idea behind Onconova Therapeutics and Ibio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk